KRSNAA Q4 FY26 Earnings Call Transcript & Analysis
FY26 Revenue ₹773 cr (+8% YoY); FY26 EBITDA ₹215 cr (+10% YoY); FY26 EBITDA Margin 27.81%. FY26 Revenue of ₹772.8 crores, up 7.76% YoY.
Read full transcript & analysis
Every earnings call for KRSNAA — management tone, guidance, KPIs and promise tracking, quarter by quarter.
KRSNAA · 6 transcripts · Healthcare · latest Q4 FY26FY26 Revenue ₹773 cr (+8% YoY); FY26 EBITDA ₹215 cr (+10% YoY); FY26 EBITDA Margin 27.81%. FY26 Revenue of ₹772.8 crores, up 7.76% YoY.
Read full transcript & analysisRevenue from Operations ₹181 cr (+4% YoY); EBITDA ₹47 cr; EBITDA Margin 26.0%. Revenue from operations stood at ₹181.2 crores, representing approx. 4% YoY growth.
Read full transcript & analysisRevenue ₹206 cr (+11% YoY); EBITDA ₹60 cr (+18% YoY); EBITDA Margin 29.0%. Revenue of ₹206 crores, up 11% YoY.
Read full transcript & analysisRevenue 1930 million (+13% YoY); EBITDA 524 million (+19% YoY); EBITDA Margin 27.0%. Revenue grew 13% YoY to ₹193 crores.
Read full transcript & analysisFY25 Revenue 7172 million (+16% YoY); FY25 EBITDA 1958 million (+34% YoY); FY25 EBITDA Margin 27%. FY25 Revenue of ₹7,172 million, up 16% YoY.
Read full transcript & analysisRevenue (Q3 FY25) ₹174 cr (+10% YoY); EBITDA (Q3 FY25) ₹47 cr; EBITDA Margin (Q3 FY25) 27.0%. 9 months FY25 Revenue up 17% YoY to ₹531.1 crores.
Read full transcript & analysis